SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009247
Filing Date
2024-06-17
Accepted
2024-06-17 16:06:44
Documents
13
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20240613x8k.htm   iXBRL 8-K 56258
  Complete submission text file 0001558370-24-009247.txt   180674

Data Files

Seq Description Document Type Size
2 EX-101.SCH xlo-20240613.xsd EX-101.SCH 3249
3 EX-101.LAB xlo-20240613_lab.xml EX-101.LAB 16578
4 EX-101.PRE xlo-20240613_pre.xml EX-101.PRE 10708
16 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20240613x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 241048225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)